By Ed Silverman // May 29th, 2007 // 9:21 am
FDA To Review Tysrabi For Crohn’s Disease (Yahoo/AP); Genzyme To Buy Bioenvision For $345 Million In Cash (Yahoo/Reuters); Brazil Offers To Build AIDS Drug Plant In Mozambique (Reuters); Exelixis Names Former Novartis Director To Head Research (press release)
Comments are closed.
Comments feed for this post only.
Want to reach our audience?
Clear